The present invention relates to the use of BACE-2 inhibitors and pharmaceutical compositions comprising BACE-2 inhibitors for treating metabolic disorders related to decreased β cell mass and/or function.
本发明涉及使用
BACE-2
抑制剂和含有
BACE-2
抑制剂的药物组合物治疗与β细胞质量和/或功能下降相关的代谢性疾病。